UNITEDHEALTH GROUP INC
▲ 0 upgrades / ▼ 0 downgrades / 9 reiterations from 8 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 22, 2026 | Mizuho | maintain | Outperform → Outperform | $500 | 52% |
| Oct 20, 2026 | RBC Capital | maintain | Outperform → Outperform | $498 | 55% |
| Oct 16, 2026 | Bernstein | maintain | Outperform → Outperform | $500 | 52% |
| Oct 16, 2026 | JP Morgan | maintain | Overweight → Overweight | $524 | 55% |
| Oct 15, 2026 | TD Cowen | reiterate | Hold → Hold | $402 | 54% |
| Oct 14, 2026 | Piper Sandler | maintain | Overweight → Overweight | $504 | 54% |
| Oct 14, 2026 | Barclays | maintain | Overweight → Overweight | $440 | 53% |
| Oct 14, 2026 | Baird | maintain | Neutral → Neutral | $427 | 55% |
| Oct 9, 2026 | TD Cowen | maintain | Hold → Hold | $402 | 54% |
| Jul 21, 2026 | JP Morgan | maintain | Overweight → Overweight | $516 | 55% |
| Jul 21, 2026 | Mizuho | maintain | Outperform → Outperform | $493 | 52% |
| Jul 20, 2026 | Barclays | maintain | Overweight → Overweight | $441 | 53% |
| Jul 17, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $529 | 54% |
| Jul 17, 2026 | Keybanc | maintain | Overweight → Overweight | $500 | 52% |
| Jul 17, 2026 | Oppenheimer | maintain | Outperform → Outperform | $500 | 52% |
| Jul 17, 2026 | Truist Securities | maintain | Buy → Buy | $500 | 54% |
| Jul 17, 2026 | RBC Capital | maintain | Outperform → Outperform | $478 | 55% |
| Jul 17, 2026 | UBS | maintain | Buy → Buy | $490 | 54% |
| Jul 16, 2026 | Baird | upgrade | Underperform → Neutral | $453 | 55% |
| Jul 14, 2026 | TD Cowen | maintain | Hold → Hold | $430 | 54% |
| Jul 14, 2026 | Truist Securities | maintain | Buy → Buy | $480 | 54% |
| Jul 14, 2026 | Keybanc | maintain | Overweight → Overweight | $475 | 52% |
| Jul 13, 2026 | Wells Fargo | maintain | Overweight → Overweight | $485 | 54% |
| Jul 9, 2026 | RBC Capital | maintain | Outperform → Outperform | $463 | 55% |
| Jul 6, 2026 | HSBC | maintain | Hold → Hold | $380 | 52% |
| Jun 30, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $468 | 54% |
| Jun 24, 2026 | B of A Securities | maintain | Buy → Buy | $475 | 53% |
| Jun 17, 2026 | Leerink Partners | maintain | Outperform → Outperform | $462 | 51% |
| Jun 8, 2026 | Mizuho | maintain | Outperform → Outperform | $460 | 52% |
| Jun 8, 2026 | JP Morgan | maintain | Overweight → Overweight | $466 | 55% |
| Jun 4, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $453 | 54% |
| Jun 4, 2026 | B of A Securities | upgrade | Neutral → Buy | $450 | 53% |
| Jun 1, 2026 | Truist Securities | maintain | Buy → Buy | $440 | 54% |
| May 27, 2026 | Bernstein | maintain | Outperform → Outperform | $492 | 52% |
| May 26, 2026 | Barclays | maintain | Overweight → Overweight | $429 | 53% |
| May 22, 2026 | UBS | maintain | Buy → Buy | $460 | 54% |
| May 20, 2026 | Mizuho | maintain | Outperform → Outperform | $440 | 52% |
| Apr 28, 2026 | JP Morgan | maintain | Overweight → Overweight | $420 | 55% |
| Apr 23, 2026 | TD Cowen | maintain | Hold → Hold | $337 | 54% |
| Apr 22, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $395 | 54% |
| Apr 22, 2026 | Argus Research | upgrade | Hold → Buy | $400 | 54% |
| Apr 22, 2026 | Wells Fargo | maintain | Overweight → Overweight | $397 | 54% |
| Apr 22, 2026 | RBC Capital | maintain | Outperform → Outperform | $400 | 55% |
| Apr 22, 2026 | Leerink Partners | maintain | Outperform → Outperform | $400 | 51% |
| Apr 22, 2026 | Oppenheimer | maintain | Outperform → Outperform | $405 | 52% |
| Apr 22, 2026 | Baird | maintain | Underperform → Underperform | $287 | 55% |
| Apr 22, 2026 | Barclays | maintain | Overweight → Overweight | $373 | 53% |
| Apr 22, 2026 | Truist Securities | reiterate | Buy → Buy | $395 | 54% |
| Apr 20, 2026 | Jefferies | maintain | Buy → Buy | $373 | 52% |
| Apr 7, 2026 | Bernstein | maintain | Outperform → Outperform | $411 | 52% |
No cross-platform signals in the last 90 days